New evidence on the HIV epidemic in Libya: Why countries must implement prevention programs among people who inject drugs

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 5, 2013, Pages 577-583

  Mirzoyan, Lusine ^a   Berendes, Sima ^a   Jeffery, Caroline ^a   Thomson, Joanna ^b   Othman, Hussain Ben ^c   Danon, Leon ^b   Turki, Abdullah A ^a   Saffialden, Rabea ^a   Valadez, Joseph J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c National Centre of Disease Control   (Libyan Arab Jamahiriya)

Author keywords

Harm reduction; HIV; Injecting drug use; Libya; North Africa; Respondentdriven sampling

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; EDUCATIONAL STATUS; EPIDEMIC; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INJECTION; LIBYAN ARAB JAMAHIRIYA; MAJOR CLINICAL STUDY; MALE; MISCELLANEOUS NAMED GROUPS; MIXED INFECTION; PATIENT COUNSELING; PEOPLE WHO INJECT DRUG; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADULT; CROSS-SECTIONAL STUDIES; DRUG USERS; EPIDEMICS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; LIBYA; LOGISTIC MODELS; MALE; NEEDLE SHARING; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 84876420689     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318284714a     Document Type: Article

References (35)

1. Abu-Raddad L, Ayodeji Akala F, Semini I, et al. Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa: Time for Strategic Action. Washington, DC: The World Bank; 2010.
2. World Bank. Preventing HIV/AIDS in the Middle East and North Africa: A Window of Opportunity to Act. Washington, DC: The World Bank; 2005.
3. Abu-Raddad LJ, Hilmi N, Mumtaz G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS. 2010;24(suppl 2):S5-S23.
4. Yerly S, Quadri R, Negro F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis. 2001;184:369-372.
5. Roberts RJ. An open letter to Colonel Muammar al-Gaddafi. Nature. 2006;444:146.
6. Free at last. Nature. 2007;448:511.
7. Rachlis B, Brouwer KC, Mills EJ, et al. Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge. Drug Alcohol Depend. 2007;90:107-119.
8. Friedman SR, Bolyard M, Mateu-Gelabert P, et al. Some data-driven reflections on priorities in AIDS network research. AIDS Behav. 2007; 11:641-651.
9. El-Gadi S, Sammud M, Abudher A. The HIV epidemic in Libya: A window on North Africa & the Middle East. Poster presented at: 8th International AIDS Impact Conference; July 1-4, 2007; Marseille, France.
10. Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571-583.
11. National AIDS Program, Libyan Arab Jamahiriya. UNGASS Country Progress Report Libya, Reporting Period: January 2010-December 2011. Libya, Africa: Ministry of Health; 2012.
12. Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7:99-106.
13. Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49:11-34.
14. Malekinejad M, Johnston LG, Kendall C, et al. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(suppl 4): S105-S130.
15. Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociological Methodol. 2004; 3:193-239.
16. Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health. 2006;83(suppl 6): 98-112.
17. UNAIDS. 09 United Nations General Assembly Special Session on HIV/AIDS -Monitoring the Declaration of Commitment on HIV/AIDS: Guidelines on Construction of Core Indicators: 2010 Reporting. Geneva, Switzerland: UNAIDS; 2010.
18. Family Health International. Behavioral Surveillance Surveys: Guidelines for Repeated Behavioral Surveys in Populations at Risk of HIV. Arlington, VA: Family Health International; 2000.
19. Frost SD, Brouwer KC, Firestone Cruz MA, et al. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence. J Urban Health. 2006;83(suppl 6):83-97.
20. Johnston LG. Conducting Respondent Driven Sampling (RDS) Studies in Diverse Settings: A Training Manual for Planning RDS Studies. Arlington, VA: Centers for Disease Control and Prevention, Atlanta, GA and Family Health International; 2007.
21. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Official Stat. 2008;24:79.
22. Volz E, Wejnert C, Degani I, et al. Respondent-Driven Sampling Analysis Tool (RDSAT). Ithaca, NY: Cornell University; 2007.
23. The Reference Group to the UN on HIV and Injecting Drug Use. Consensus Statement of the Reference group to the United Nations on HIV and Injecting Drug Use 2010. Available at: http://www.unodc.org/documents/hiv-aids/publications/ 2010-UN-IDU-Ref-Group-Statement.pdf. Accessed February 15, 2013.
24. Des Jarlais DC, Feelemyer JP, Modi SN, et al. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124:95-107.
25. WHO, UNAIDS, UNICEF. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access, Progress Report 2011. Geneva, Switzerland: World Health Organization; 2011. Available at: http://www.who.int/ hiv/pub/progress-report2011/en/index.html. Accessed February 15, 2013.
26. Toufik A. Supporting the development and implementation of a national HIV/AIDS strategy in Libya: Mission report June 2nd-23rd, 2010: Liverpool School of Tropical Medicine (Project sponsored by the European Commission). Liverpool, United Kingdom: Liverpool School of Tropical Medicine; 2010.
27. République Tunisienne, Ministère de la Santé Publique. 2010-2011 Rapport d'Activité sur la Riposte au SIDA-Tunisie, Mars 2012: République Tunisienne, Ministère de la Santé Publique, Direction des Soins de Santé de Base, Programme National de Lutte contre le sida et les MST. Geneva, Switzerland: UNAIDS; 2012. Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/ countryprogressreports/2012countries/ce-TN-Narrative-Report[1].pdf. Accessed February 15, 2013.
28. National AIDS Program E. Global AIDS Response Progress Report 2012, Arab Republic of Egypt. Geneva, Switzerland: UNAIDS; 2012. Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/ 2012countries/ce-EG-Narrative-Report[1].pdf. Accessed February 15, 2013.
29. Beyrer C, Baral S, Shaboltas A, et al. The feasibility of HIV vaccine efficacy trials among Russian injection drug users. Vaccine. 2007;25: 7014-7016.
30. AIDS Projects Management Group of Australia and Switzerland. A Rapid Assessments of HIV/AIDS and Injecting Drug Use in Algeria, Egypt, Iran, Libya, Morocco and Oman: Findings and Lessons Learned. Newtown, Australia: Aids Projects Management Group; 2008. Available at: http://www.aidsprojects.com/wp- content/uploads/2011/05/MENARapid-Assessment-Report.pdf. Accessed February 15, 2013.
31. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014-1028.
32. Joint United Nations Programme on HIV/AIDS. High Coverage Sites: HIV Prevention Among Injecting Drug Users in Transitional and Developing Countries, Case Studies. Geneva, Switzerland: UNAIDS; 2006.
33. Horton R, Das P. Rescuing people with HIV who use drugs. Lancet. 2010;376:207-208.
34. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, et al. 12 Myths about HIV/AIDS and people who use drugs. Lancet. 2010;376:208-211.
35. Degenhardt L, Mathers B, Vickerman P, et al. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285-301.